Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties

Journal of Biological Chemistry

Volumn 291, Issue 22, 2016, Pages 11657-11675

  Watkins, Harriet A ^a,b   Chakravarthy, Madhuri ^a   Abhayawardana, Rekhati S ^a   Gingell, Joseph J ^a,b   Garelja, Michael ^a   Pardamwar, Meenakshi ^c   McElhinney, James M W R ^c   Lathbridge, Alex ^c   Constantine, Arran ^c   Harris, Paul W R ^b   Yuen, Tsz Ying ^b   Brimble, Margaret A ^b   Barwell, James ^d   Poyner, David R ^d   Woolley, Michael J ^e   Conner, Alex C ^e   Pioszak, Augen A ^f   Reynolds, Christopher A ^c   Hay, Debbie L ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF ESSEX   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; CARDIOVASCULAR SYSTEM; CHEMICAL ACTIVATION; CONFORMATIONS; PEPTIDES;

ADRENOMEDULLIN RECEPTORS; ALLOSTERIC MECHANISMS; CALCITONIN RECEPTOR-LIKE RECEPTORS; ELECTROSTATIC POTENTIALS; G PROTEIN COUPLED RECEPTORS; MOLECULAR PROPERTIES; PHYSIOLOGICAL EFFECTS; RECEPTOR ACTIVITY-MODIFYING PROTEINS;

PROTEINS;

ADRENOMEDULLIN 1 RECEPTOR; ADRENOMEDULLIN 2 RECEPTOR; ADRENOMEDULLIN RECEPTOR; CALCITONIN RECEPTOR; CYCLIC AMP; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; UNCLASSIFIED DRUG; ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; CALCRL PROTEIN, HUMAN; PROTEIN BINDING; RAMP2 PROTEIN, HUMAN; RAMP3 PROTEIN, HUMAN;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; SEQUENCE ALIGNMENT; X RAY CRYSTALLOGRAPHY;

ADRENOMEDULLIN; AMINO ACID SEQUENCE; CALCITONIN RECEPTOR-LIKE PROTEIN; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RECEPTORS, ADRENOMEDULLIN; SEQUENCE ALIGNMENT;

EID: 84971290136     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.688218     Document Type: Article

References (79)

1. Nishikimi, T., Kuwahara, K., Nakagawa, Y., Kangawa, K., and Nakao, K. (2013) Adrenomedullin in cardiovascular disease: a useful biomarker, its pathological roles and therapeutic application. Curr. Protein Pept. Sci. 14, 256-267
2. Manuela, C., Laura, S., Benedetta, S., Raffaele, C., Alessandro, V., Chiara, C., Tommaso, P., Daniela, G., and Silvia, D. R. (2014) Adrenomedullin and intermedin gene transcription is increased in leukocytes of patients with chronic heart failure at different stages of the disease. Peptides 55, 13-16
3. Wong, C. P., Loh, S. Y., Loh, K. K., Ong, P. J., Foo, D., and Ho, H. H. (2012) Acute myocardial infarction: clinical features and outcomes in young adults in Singapore. World J. Cardiol. 4, 206-210
4. Burley, D. S., Hamid, S. A., and Baxter, G. F. (2007) Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail. Rev. 12, 279-291
5. Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Oya, H., Kyotani, S., Sakamaki, F., Ueno, K., Nakanishi, N., Miyatake, K., and Kangawa, K. (2000) Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart 84, 653-658
6. Lainchbury, J. G., Nicholls, M. G., Espiner, E. A., Yandle, T. G., Lewis, L. K., and Richards, A. M. (1999) Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension 34, 70-75
7. Kataoka, Y., Miyazaki, S., Yasuda, S., Nagaya, N., Noguchi, T., Yamada, N., Morii, I., Kawamura, A., Doi, K., Miyatake, K., Tomoike, H., and Kangawa, K. (2010) The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction. J. Cardiovasc. Pharmacol. 56, 413-419
8. Dupuis, J., Caron, A., and Ruël, N. (2005) Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin. Clin. Sci. 109, 97-102
9. Kato, J., and Kitamura, K. (2015) Bench-to-bedside pharmacology of adrenomedullin. Eur. J. Pharmacol. 764, 140-148
10. Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., and Foord, S. M. (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54, 233-246
11. Dackor, R. T., Fritz-Six, K., Dunworth, W. P., Gibbons, C. L., Smithies, O., and Caron, K. M. (2006) Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol. Cell. Biol. 26, 2511-2518
12. Dackor, R., Fritz-Six, K., Smithies, O., and Caron, K. (2007) Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J. Biol. Chem. 282, 18094-18099
13. Caron, K. M., and Smithies, O. (2001) Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc. Natl. Acad. Sci. U.S.A. 98, 615-619
14. Yoshizawa, T., Sakurai, T., Kamiyoshi, A., Ichikawa-Shindo, Y., Kawate, H., Iesato, Y., Koyama, T., Uetake, R., Yang, L., Yamauchi, A., Tanaka, M., Toriyama, Y., Igarashi, K., Nakada, T., Kashihara, T., et al. (2013) Novel regulation of cardiac metabolism and homeostasis by the adrenomedullin-receptor activity-modifying protein 2 system. Hypertension 61, 341-351
15. Liang, L., Tam, C. W., Pozsgai, G., Siow, R., Clark, N., Keeble, J., Husmann, K., Born, W., Fischer, J. A., Poston, R., Shah, A., and Brain, S. D. (2009) Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice. Hypertension 54, 1254-1261
16. Barrick, C. J., Lenhart, P. M., Dackor, R. T., Nagle, E., and Caron, K. M. (2012) Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner. J. Mol. Cell Cardiol. 52, 165-174
17. Yamauchi, A., Sakurai, T., Kamiyoshi, A., Ichikawa-Shindo, Y., Kawate, H., Igarashi, K., Toriyama, Y., Tanaka, M., Liu, T., Xian, X., Imai, A., Zhai, L., Owa, S., Arai, T., and Shindo, T. (2014) Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system. J. Mol. Cell. Cardiol. 77, 73-85
18. Tadokoro, K., Nishikimi, T., Mori, Y., Wang, X., Akimoto, K., and Matsuoka, H. (2003) Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension. Regul. Pept. 112, 71-78
19. Garland, S. L. (2013) Are GPCRs still a source of new targets? J. Biomol. Screen. 18, 947-966
20. Hollenstein, K., de Graaf, C., Bortolato, A., Wang, M. W., Marshall, F. H., and Stevens, R. C. (2014) Insights into the structure of class B GPCRs. Trends Pharmacol. Sci. 35, 12-22
21. Booe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., Poyner, D. R., Hay, D. L., and Pioszak, A. A. (2015) Structural basis for receptor activity-modifying protein-dependent selective peptide recognition by a G protein-coupled receptor. Mol. Cell 58, 1040-1052
22. Watkins, H. A., Walker, C. S., Ly, K. N., Bailey, R. J., Barwell, J., Poyner, D. R., and Hay, D. L. (2014) Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology. Br. J. Pharmacol. 171, 772-788
23. Qi, T., Dong, M., Watkins, H. A., Wootten, D., Miller, L. J., and Hay, D. L. (2013) Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT (a) function. Br. J. Pharmacol. 168, 644-657
24. Barwell, J., Conner, A., and Poyner, D. R. (2011) Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function. Biochim. Biophys. Acta 1813, 1906-1916
25. Qi, T., Christopoulos, G., Bailey, R. J., Christopoulos, A., Sexton, P. M., and Hay, D. L. (2008) Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol. Pharmacol. 74, 1059-1071
26. Woolley, M. J., Watkins, H. A., Taddese, B., Karakullukcu, Z. G., Barwell, J., Smith, K. J., Hay, D. L., Poyner, D. R., Reynolds, C. A., and Conner, A. C. (2013) The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach. J. R. Soc. Interface 10, 20130589
27. Bailey, R. J., and Hay, D. L. (2006) Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27, 1367-1375
28. Harris, P. W. R., Yang, S. H., and Brimble, M. A. (2011) An improved procedure for the preparation of aminomethyl polystyrene resin and its use in solid phase (peptide) synthesis. Tetrahedron Lett. 52, 6024-6026
29. Harris, P. W. R., Williams, G. M., Shepherd, P., and Brimble, M. A. (2008) The synthesis of phosphopeptides using microwave-assisted solid phase peptide synthesis. Int. J. Pept. Res. Ther. 14, 387-392
30. Vohra, S., Taddese, B., Conner, A. C., Poyner, D. R., Hay, D. L., Barwell, J., Reeves, P. J., Upton, G. J., and Reynolds, C. A. (2013) Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies. J. R. Soc. Interface 10, 20120846
31. Gingell, J. J., Qi, T., Bailey, R. J., and Hay, D. L. (2010) A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor. Peptides 31, 1400-1404
32. McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., and Foord, S. M. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339
33. Bailey, R. J., and Hay, D. L. (2007) Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br. J. Pharmacol. 151, 678-687
34. Conner, A. C., Hay, D. L., Simms, J., Howitt, S. G., Schindler, M., Smith, D. M., Wheatley, M., and Poyner, D. R. (2005) A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. Mol. Pharmacol. 67, 20-31
35. Kenakin, T. P. (2014) A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery, 4th Ed., pp. 181-211, Elsevier, Amsterdam
36. Lock, A., Forfar, R., Weston, C., Bowsher, L., Upton, G. J. G., Reynolds, C. A., Ladds, G., and Dixon, A. M. (2014) One motif to bind them: a small-XXX-small motif affects transmembrane domain 1 oligomerization, function, localization, and cross-talk between two yeast GPCRs. Biochim. Biophys. Acta 1838, 3036-3051
37. Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J., Honig, B., Shaw, D. E., and Friesner, R. A. (2004) A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351-367
38. Watkins, H. A., Au, M., and Hay, D. L. (2012) The structure of secretin family GPCR peptide ligands: implications for receptor pharmacology and drug development. Drug Discov. Today 17, 1006-1014
39. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948
40. Pérez-Castells, J., Martín-Santamaría, S., Nieto, L., Ramos, A., Martínez, A., Pascual-Teresa, B., and Jiménez-Barbero, J. (2012) Structure of micelle-bound adrenomedullin: a first step toward the analysis of its interactions with receptors and small molecules. Biopolymers 97, 45-53
41. Taddese, B., Upton, G. J. G., Bailey, G. R., Jordan, S. R. D., Abdulla, N. Y., Reeves, P. J., and Reynolds, C. A. (2014) Do plants contain G protein-coupled receptors? Plant Physiol. 164, 287-307
42. Runge, S., Thøgersen, H., Madsen, K., Lau, J., and Rudolph, R. (2008) Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J. Biol. Chem. 283, 11340-11347
43. Siu, F. Y., He, M., de Graaf, C., Han, G. W., Yang, D., Zhang, Z., Zhou, C., Xu, Q., Wacker, D., Joseph, J. S., Liu, W., Lau, J., Cherezov, V., Katritch, V., Wang, M. W., and Stevens, R. C. (2013) Structure of the human glucagon class B G-protein-coupled receptor. Nature 499, 444-449
44. Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M. Y., Pieper, U., and Sali, A. (2007) Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 10.1002/0471140864.ps0209s50
45. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graphics 14, 33-38
46. Colovos, C., and Yeates, T. O. (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2, 1511-1519
47. 2 adrenergic receptor-Gs protein complex. Nature 477, 549-555
48. Roy, A., Taddese, B., Vohra, S., Thimmaraju, P. K., Illingworth, C. J. R., Simpson, L. M., Mukherjee, K., Reynolds, C. A., and Chintapalli, S. V. (2014) Identifying subset errors in multiple sequence alignments. J. Biomol. Struct. Dyn. 32, 364-371
49. Baldwin, J. M., Schertler, G. F. X., and Unger, V. M. (1997) An α-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors, J. Mol. Biol. 272, 144-164
50. Hollenstein, K., Kean, J., Bortolato, A., Cheng, R. K., Doré, A. S., Jazayeri, A., Cooke, R. M., Weir, M., and Marshall, F. H. (2013) Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature 499, 438-443
51. Wootten, D., Reynolds, C. A., Koole, C., Smith, K. J., Mobarec, J. C., Simms, J., Quon, T., Furness, S. G., Miller, L. J., Christopoulos, A., and Sexton, P. M. (2016) A hydrogen-bonded polar network in the core of the glucagon-like peptide-1 receptor is a fulcrum for biased agonism: lessons from class B crystal structures. Mol. Pharmacol. 89, 335-347
52. Hussein, H. A., Borrel, A., Geneix, C., Petitjean, M., Regad, L., and Camproux, A. C. (2015) PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins. Nucleic Acids Res. 43, W436-W442
53. Borrel, A., Regad, L., Xhaard, H., Petitjean, M., and Camproux, A. C. (2015) Pock drug: a model for predicting pocket druggability that overcomes pocket estimation uncertainties. J. Chem. Inf. Model. 55, 882-895
54. Volkamer, A., Kuhn, D., Rippmann, F., and Rarey, M. (2012) DoGSite-Scorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28, 2074-2075
55. Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., and Sexton, P. M. (2013) Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc. Natl. Acad. Sci. U.S.A. 110, 5211-5216
56. Yang, L., Yang, D., de Graaf, C., Moeller, A., West, G. M., Dharmarajan, V., Wang, C., Siu, F. Y., Song, G., Reedtz-Runge, S., Pascal, B. D., Wu, B., Potter, C. S., Zhou, H., Griffin, P. R., et al. (2015) Conformational states of the full-length glucagon receptor. Nat. Commun 6, 7859
57. Koth, C. M., Murray, J. M., Mukund, S., Madjidi, A., Minn, A., Clarke, H. J., Wong, T., Chiang, V., Luis, E., Estevez, A., Rondon, J., Zhang, Y., Hötzel, I., Allan, B. B. (2012) Molecular basis for negative regulation of the glucagon receptor. Proc. Natl. Acad. Sci. U.S.A. 109, 14393-14398
58. Monaghan, P., Thomas, B. E., Woznica, I., Wittelsberger, A., Mierke, D. F., and Rosenblatt, M. (2008) Mapping peptide hormone-receptor interactions using a disulfide-trapping approach. Biochemistry 47, 5889-5895
59. Wheatley, M., Wootten, D., Conner, M. T., Simms, J., Kendrick, R., Logan, R. T., Poyner, D. R., and Barwell, J. (2012) Lifting the lid on GPCRs: the role of extracellular loops. Br. J. Pharmacol. 165, 1688-1703
60. Harikumar, K. G., Simms, J., Christopoulos, G., Sexton, P. M., and Miller, L. J. (2009) Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor. Biochemistry 48, 11773-11785
61. Koole, C., Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., and Sexton, P. M. (2012) Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. J. Biol. Chem. 287, 3642-3658
62. Bortolato, A., Doré, A. S., Hollenstein, K., Tehan, B. G., Mason, J. S., and Marshall, F. H. (2014) Structure of class B GPCRs: new horizons for drug discovery. Br. J. Pharmacol. 171, 3132-3145
63. Gingell, J. J., Simms, J., Barwell, J., Poyner, D. R., Watkins, H. A., Pioszak, A. A., Sexton, P. M., and Hay, D. L. (2016) An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology. Cell Discov., in press
64. Lee S. M., Hay, D. L., and Pioszak, A. A. (2016) Calcitonin and amylin receptor peptide interaction mechanisms: insights into peptide-binding modes and allosteric modulation of the calcitonin receptor by receptor activity-modifying proteins. J. Biol. Chem. 291, 8686-8700
65. Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., and Wolfson, H. J. (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 33, W363-W367
66. Kozakov, D., Hall, D. R., Beglov, D., Brenke, R., Comeau, S. R., Shen, Y., Li, K., Zheng, J., Vakili, P., Paschalidis, I. C., and Vajda, S. (2010) Achieving reliability and high accuracy in automated protein docking: ClusPro, PIPER, SOU, and stability analysis in CAPRI rounds 13-19. Proteins 78, 3124-3130
67. Li, X., Moal, I. H., and Bates, P. A. (2010) Detection and refinement of encounter complexes for protein-protein docking: taking account of macromolecular crowding. Proteins 78, 3189-3196
68. Andrusier, N., Nussinov, R., and Wolfson, H. J. (2007) FireDock: fast interaction refinement in molecular docking. Proteins 69, 139-159
69. Mashiach, E., Schneidman-Duhovny, D., Andrusier, N., Nussinov, R., and Wolfson, H. J. (2008) FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 36, W229-W232
70. Gray, J. J., Moughon, S., Wang, C., Schueler-Furman, O., Kuhlman, B., Rohl, C. A., and Baker, D. (2003) Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J. Mol. Biol. 331, 281-299
71. Wang, D. F., Wiest, O. G., and Helquist, P. (2005) Homology modeling, docking and molecular dynamics simulation of class IHDACs. Abstr. Papers Am. Chem. Soc. 230, U1360-U1361
72. Wang, J. G., Xiao, Y. J., Li, Y. H., Ma, Y., and Li, Z. M. (2007) Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach. Bioorg. Med. Chem. 15, 374-380
73. Clamp, M., Cuff, J., Searle, S. M., and Barton, G. J. (2004) The Jalview Java alignment editor. Bioinformatics 20, 426-427
74. Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., and Baker, N. A. (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35, W522-W525
75. Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., and Baker, N. A. (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665-W667
76. Callenberg, K. M., Choudhary, O. P., de Forest, G. L., Gohara, D. W., Baker, N. A., and Grabe, M. (2010) APBSmem: a graphical interface for electrostatic calculations at the membrane. PLoS One 10.1371/journal.pone.0012722
77. Sitkoff, D., Sharp, K. A., and Honig, B. (1994) Correlating solvation free energies and surface tensions of hydrocarbon solutes. Biophys. Chem. 51, 397-403; discussion 404-399
78. Jo, S., Kim, T., Iyer, V. G., and Im W. (2008) CHARMM-GUI: a Web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859-1865
79. Miller, L. J., Chen, Q., Lam, P. C., Pinon, D. I., Sexton, P. M., Abagyan, R., and Dong, M. (2011) Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling. J. Biol. Chem. 286, 15895-15907